Thrombocytosis and Thrombocythemia: The Laboratory and Clinical Significance of an Elevated Platelet Count
|
|
- Roberta Stokes
- 6 years ago
- Views:
Transcription
1 Thrombocytosis and Thrombocythemia: The Laboratory and Clinical Significance of an Elevated Platelet Count WILLIAM M. DAVIS, M.D., AND ALICIA O. MENDEZ ROSS, M.D. Departments of Medicine and Pathology, Hematology Service and Hematology Laboratory, Springfield Hospital Medical Center, Springfield, Massachusetts ABSTRACT Davis, William M., and Ross, Alicia O. Mendez: Thrombocytosis and thrombocythemia: The laboratory and clinical significance of an elevated platelet count. Am. J. Clin. Pathol. 59: , One hundred consecutive patients with elevated platelet counts (more than 500,000 per cu. mm.) seen in a 16-month period have been studied. Thirty-six were found to have underlying malignant disease. Fifteen of the patients had recently undergone splenectomy, and four patients had recently had other major surgery. Five of the patients had polycythemia vera, and one patient had chronic granulocytic leukemia. Iron deficiency anemia was associated with thrombocytosis in eight patients. There were 24 patients with miscellaneous benign conditions and seven patients with collagen disorders, usually rheumatoid arthritis. The thrombocytosis of malignant disease was frequently unexpected and was an important clue to the presence of a disseminated malignancy. AN ELEVATED PLATELET COUNT has been re- underlying diseases. On the other hand, ported in a number of clinical conditions. 2 - thrombocythemia refers to a marked and 4-7, D, ii, i2, i4, IB This elevation undoubtedly persistent elevation of the platelet count reflects an increase in the rate of thrombo- as part of a myeloproliferative disorder, cyte production and release rather than a often with systemic manifestations, prolongation of the platelet life span. The Thrombocytosis associated with a numspecific stimulus for such production in- ber of diseases is well known to most phycrease or release is still unknown. How- sicians. Thrombocytosis has been docuever, several investigators have suggested a mented in diseases such as chronic inflamhumoral mechanism. l > S The concept matory bowel disease, 7 rheumatoid arthriof a feedback mechanism 1 has also been tis, acute infections, and trauma, and has suggested. also been noted following major surgical Ginsburg and Aster 5 have defined throm- procedures, 4 particularly splenectomy. Fibocytosis as a moderate, short-lived, and nally, thrombocytosis may be the clue of symptomless elevation of platelet count an underlying malignancy in some patients that occurs in association with certain in whom the diagnosis is not yet suspected or established. 5 A re-evaluation of the signia R n e u C stip d t MarchTo, IW^SfS? pus lion March 29, "ificance of an elevated platelet count in a large general hospital seemed desirable. 243
2 244 DAVIS AND ROSS A..J.C.P. Vol. 59 Methods and Results One hundred consecutive patients with elevated platelet counts (more than 500,000 per cu. mm.) seen in a 475-bed general hospital during a 16-month period from May 1968 through August 1969 were studied. During this period of time the Hematology Laboratory performed 3,642 platelet counts on blood from 907 patients, from whom these 100 consecutive patients were culled. Inpatients as well as outpatients were included in the study. During the 16- month period there were 17,439 patient admissions. Platelets were counted by phase contrast microscopy by the method of Brecher and Cronkite. 3 These authors have reported the mean platelet count as 257,000 per cu. mm. The distribution of these counts was skewed to the right and statistical estimation of the 95% limits of variation of such single counts was 140,000 to 440,000 per cu. mm. Sloan 16 reports a similar mean and range. We have accepted that the normal platelet count ranges from 150,000 to 450,000 per cu. mm. For the purpose of this study, any patient with a platelet count of 500,000 per cu. mm. or more was included. The observed platelet counts ranged from 500,000 to 1,500,000 per cu. mm. The initial clue to the presence of thrombocytosis was often the review of the peripheral blood smear. Thus, the platelet count was frequently carried out because the technician had reported the number of platelets to be "increased." In this study there were 60 women and 40 men. There were 15 patients from 0 to 9 years of age and 33 patients in the fourth and fifth decades of life. It is probable that this pattern represents the hospital population age distribution. Table 1 shows the major causes of thrombocytosis in this study. The largest group of patients with thrombocytosis were the 36 patients with malignancies. The breakdown as to primary tumors was as follows: carcinoma of the ovary, seven; carcinoma of the breast, five; carcinoma of the lung, four; carcinoma of the pancreas, three; carcinoma of the colon, four; metastatic adenocarcinoma, primary site undetermined, two; miscellaneous carcinoma, two; malignant melanoma, two; malignant lymphoma (including Hodgkin's disease), seven. In none of our patients did we find early small localized tumors; in almost all cases the malignancy was disseminated. However, the presence of malignant disease was often not strongly suspected. There were six patients with myeloproliferative disease. Five patients had polycythemia vera and one patient had chronic granulocytic leukemia. During this period of study, no patients with myelofibrosis or essential thrombocythemia were observed. Among those patients with thrombocytosis occurring after surgical procedures, the most common operation was recent splenectomy in 15 patients as follows: in four adult patients with chronic idiopathic thrombocytopenia purpura (early thrombocytosis represented an immediate therapeutic response); in five patients because of trauma; and in six patients for hemolytic anemias of several types. There were four patients who had recently had major surgery as follows: gastrectomy for massive gastrointestinal bleeding, bowel resection for chronic inflammatory bowel disease, craniotomy for subarachnoid hemorrhage, and cholecystectomy for chronic cholecystitis. There were eight cases of well-documented iron deficiency anemia; five of these patients were in the pediatric age group. None of the three adult patients had underlying malignancy. There were seven patients with collagen disorders, usually rheumatoid arthritis. There were 24 patients with miscellaneous disorders: eight had acute infection, five had cardiac disease, and five had either chronic pancreatitis or cirrhosis of the liver, or both.
3 February 1973 SIGNIFICANCE OF THROMBOCYTOSIS 245 One patient admitted with anemia, leukopenia, and severe thrombocytopenia (platelet count less than 10,000 per cu. mm.) was found to have Addisonian pernicious anemia. During the immediate response to vitamin B 12 therapy the platelet count rose to 600,000 per cu. mm. A 41- year-old woman was admitted with a left hemiplegia and found to have congenital spherocytic hemolytic anemia. She had not had a splenectomy. As part of the active hemolytic process, presumably, the platelet count was elevated to 1,018,000 per cu. mm. The patient refused the recommended splenectomy. The records of all these patients were carefully reviewed for possible associated thrombotic or hemorrhagic complications. The most striking elevations in platelet counts occurred in the patients immediately post-splenectomy. There were no complications of this type in any of these patients. No therapy such as heparinization was used. In only one of the 36 patients with disseminated malignant disease was a thrombotic episode observed. This patient, with carcinoma of the ovary, showed bilateral pulmonary emboli and multiple areas of pulmonary infarction at postmortem examination. The paradoxical risk of both hemorrhage and thrombosis in patients with polycythemia and the myeloproliferative disorders is well established. One of our patients with untreated polycythemia presented with a left hemiplegia clue to cerebral thrombosis. In addition, one patient with polycythemia vera at the time of surgery demonstrated significant postoperative bleeding, primarily from the upper gastrointestinal tract. Discussion Since Riess 11 first observed the association of malignancy and thrombocytosis in 1872, several investigators have reported similar findings. However, these early re- Table 1. Causes of Thrombocytosis Disease or Condition No. of Patients Malignancy 36 Polycythemia vera 5 Chronic granulocytic leukemia 1 Surgery Splenectomy 15 Other 4 Iron deficiency anemia S Klieumatoid arthritis or other collagen disorders 7 Miscellaneous 24 TOTAL 100 ports appeared principally in the European literature. 2 ' u More reports, however, are now appearing in the U. S. medical journals. 6 ' 14 ' 15 One of the recent reports was the study of Levin and Conley, 6 who in 1964 surveyed 82 patients with elevated platelet counts occurring in a large group of 14,000 patients. An elevated platelet count in their study was considered to be 400,000 per cu. mm. or more. Of these 82 patients, 31 (38%) had underlying neoplasms. These authors subsequently studied another group of 240 consecutive patients with known inoperable malignancies, prior to any radiation or chemotherapy. The incidence of thrombocytosis in this series was 45%, excluding those with carcinoma of the lung; patients with carcinoma of the lung had a 38% incidence of thrombocytosis. In a more recent study, Silvis and associates 14 reviewed 190 patients with proven carcinoma of the lung and noted that 60% of these patients had significant thrombocytosis. Thrombocythemia associated with myeloproliferative disorders is well recognized, particularly polycythemia vera and chronic granulocytic leukemia in the early phases. As chronic granulocytic leukemia evolves, and partly as a result of treatment, the
4 246 DAVIS AND ROSS A.J.C.P. Vol. 59 platelet count eventually falls to the normal range and later will be significantly depressed. Myelofibrosis at some stages will often be accompanied by a significant thrombocytosis. The fourth member of the myeloproliferative group, essential thrombocythemia, is rare. In this group of patients with myeloproliferative disorders there will usually be significant platelet morphologic abnormalities, particularly variation in size and the presence of giant forms. Recent surgery as a cause of increased platelet counts is also well established. The recent study of Breslow and co-workers* showed that this thrombocytosis could occur after a variety of major surgical procedures but was most frequent after splenectomy. After major procedures other than splenectomy there was often an initial decrease in platelet count followed by elevation to supranormal levels. The thrombocytosis was associated with an increase in circulating megakaryocytes and megakaryocytic fragments caused by an unknown mechanism. The increase after splenectomy was often seen immediately postoperatively, but sometimes it was delayed significantly for 3 to 10 days. The platelet counts after splenectomy usually peaked at about 3 to 4 weeks, but tended to persist for many months and years after the operation. Various benign conditions have been associated with elevated platelet counts. This was discussed by Silvis and co-workers 15 in their review of 322 patients with thrombocytosis. Of these, 116 cases (36%) were associated with "benign" conditions such as iron deficiency, recent hemorrhage, chronic inflammatory bowel disease, cirrhosis, alcoholism, rheumatoid arthritis, pernicious anemia (as part of the response to initial therapy), and tuberculosis. Thrombocytosis seen in patients responding to vitamin B ]2 therapy for Addisonian pernicious anemia has been documented by Ogston and Dawson." The increase in platelets began with and corresponded to the start of the reticulocyte response. The peak platelet count was usually reached about 9 to 12 days later. The association with iron deficiency has been observed by a number of investigators. With effective treatment of iron deficiency, the platelet count will return to normal. An additional observation of note is that platelets of iron deficiency are often small and thus "microcytic." Acute bleeding (major hemorrhage) is often followed by thrombocytosis. The mechanism of thrombocytosis in most patients with benign conditions is unknown, and the frequency of its occurrence is not high. Our group of patients with benign disorders was similar to those reported in the literature. The possibility that the elevation of the platelet count will be associated with either bleeding or thrombotic manifestations must be considered. Despite the relatively abrupt elevations in platelet counts occurring shortly after splenectomy, none of the patients showed evidence of thrombotic phenomena. Two instances of cerebral thrombosis occurred in one patient with congenital spherocytic hemolytic anemia (who had not had a splenectomy) and another patient with early untreated polycythemia vera. The medical literature is replete with documentation of the bleeding and thrombotic complications of the myeloproliferative disorders, particularly polycythemia vera. The bleeding observed appears to be related to abnormal platelet function in part, although, in polycythemia, blood viscosity and vascular factors are also important. The thrombotic complications are probably related to blood viscosity and vascular changes of aging rather than to the increased platelets. It would not appear that an elevation in platelet count per se requires therapy. However, in the myeloproliferative disorders the disease itself frequently needs therapy with alkylating
5 February 1913 SIGNIFICANCE OF THROMBOCYTOSIS 247 agents or radioactive phosphorus, which will almost always lower the platelet count significantly. In many clinical situations thrombocytosis or thrombocythemia is an expected finding. The post-splenectomy patients and those with the myeloproliferative disorders are in this category. In this series there were 19 post-surgery and post-splenectomy patients and six patients with myeloproliferative disorders. In these 25 patients the elevated platelet counts were expected. In the remaining 75 patients, including 36 patients with malignancies, the thrombocytosis could be said to have been unexpected. Thus, an unexplained thrombocytosis would appear to be associated with a 48% incidence or approximate 50/50 chance, of malignancy. This finding of a platelet "increase" or a platelet count in excess of 450,000 to 500,000 per cu. mm. has real clinical significance for the patient and his physician. References 1. Abilgaard CF, Simone VJ: Thrombopoiesis. Semin Hematol 4: , Bagdasarov AA, Rodina RI, Gefen EG: Blood platelets in cancer and peptic ulcer. Klin Med 28:39-45, Brecher G, Cronkite EP: Morphology and enumeration of human blood platelets. J Appl Physiol 3: , Breslow A, Kaufman RM, Lawsky AR: I'he effect of surgery on the concentration of circulating megakaryocytes and platelets. Blood 32: , Ginsburg AD, Aster RH: Platelet function: Its clinical significance. DM, Sept, 1970, pp Levin J, Conley CL: Thrombocytosis associated with malignant disease. Arch Intern Med 114: , Morowitz AD, Allen LW, Kirsner JB: Thrombocytosis in chronic inflammatory bowel disease. Ann Intern Med 68: , Odell TT Jr, McDonald TP, Detwiller TC: Stimulation of platelet production by serum of platelet depleted rats. Proc Soc Exp Biol Med 108: , Ogston D, Dawson AA: Thrombocytosis following thrombocytopenia in man. Postgrad Med J 45: , Pierre RV, Linman JW: Studies on thrombopoiesis. IV. Thrombocytosis-promoting activity of normal urine. Proc Soc Exp Biol Med 113: , Pranis LIU: Thrombocytopoiesis in cancer and pre-cancer of the stomach according to data on the peripheral blood and the bone marrow. Vopr Klin Lech Zlok Novoobraz 4: , Riess L: Zur pathologischen anatomic des blutes. Arch Anat Physiol Wissensch Med, 1872, pp Schulman I, Pierce M, Lukens A, et al: Studies on thrombopoiesis. I. A factor in normal human plasma required for platelet production; chronic thrombocytopenia due to its deficiency. Blood 16: , Silvis SE, Turkbas N, Doscherliolmen A: Thrombocytosis in patients with lung cancer. JAMA 211: , Silvis SE, Turkbas N, Swaim WR, et al: Causes of thrombocytosis: A clinical evaluation of 322 patients. Minn Med 52: , Sloan AW: The normal platelet count. J Clin Pathol 4:37-46, 1951
Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms
Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)
More informationMYELODYSPLASTIC AND MYELOPROLIFERATIVE
MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISORDERS Pediatric Hemato-Oncology Division Medical Faculty University of Sumatera Utara 1 MYELODYSPLASIA SYNDROME A group of disorder defect in hematopoetic cell
More informationChronic Idiopathic Myelofibrosis (CIMF)
Chronic Idiopathic Myelofibrosis (CIMF) CIMF Synonyms Agnogenic myeloid metaplasia Myelosclerosis with myeloid metaplasia Chronic granulocytic-megakaryocytic myelosis CIMF Megakaryocytic proliferation
More informationThe Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)
The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,
More informationThere are two main causes of a low platelet count
Thrombocytopenia Thrombocytopenia is a condition in which a person's blood has an unusually low level of platelets Platelets, also called thrombocytes, are found in a person's blood along with red blood
More informationLahey Clinic Internal Medicine Residency Program: Curriculum for Hematology
Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Faculty representative: Neil Weiner, MD Resident representative: Guiherme Rabinowits, MD Revision date: February 28, 2006 Goals
More information78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP)
78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP) 2011 Annual Meeting Las Vegas, NV AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 33 W. Monroe, Ste. 1600 Chicago,
More information12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization
Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal radiotherapy, toxic effects of, 636 637 Acute promyelocytic leukemia, associated with acquired bleeding problems, 614 615 Acute renal
More informationIndex. Note: Page numbers of article numbers are in boldface type.
Index Note: Page numbers of article numbers are in boldface type. A Abdomen, acute, as cancer emergency, 381 399 in cancer patients, etiologies unique to, 390 392 in perforation, 388 surgery of, portal
More informationComprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018)
Comprehensive ICD-10-CM Casefinding Code List for Reportable Tumors for 2018 (Effective Dates: 10/1/2017-9/30/2018) Please refer to your standard setter(s) for specific reporting requirements before using
More informationChapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89
Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Presented by Jennifer Kurkulonis 1 FOUR MAJOR TYPES OF BLOOD CELLS White blood cells
More informationMyeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination
Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination Arati V. Rao, M.D. Division of Medical Oncology and Geriatrics Duke University Medical Center Durham
More information74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow
74y old Female with chronic elevation of Platelet count August 18, 2005 Faizi Ali, MD Hematopathology Fellow Clinical History Patient is a 74y old otherwise healthy Caucasian female with no major complaint
More informationHu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).
Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.
More informationSecondary Gout Associated with Myeloproliferative Diseases* imt. Sinai Hospital
Chapter VI Secondary Gout Associated with Myeloproliferative Diseases* By TS'AI-FAN Yu, M.D. imt. Sinai Hospital In a variety of disorders of hemopoiesis, the turnover of nucleic acids is greatly augmented,
More informationCurriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center
MEDICAL ONCOLOGY AND HEMATOLOGY (R2, R3) A. The PURPOSE of this rotation is to afford medical residents a broad clinical and training experience in the clinical diagnosis and management of common adult
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug
More informationGeneral Pathology Theory Syllabus for II B.D.S.
General Pathology Theory Syllabus for II B.D.S. Sr. No. Topic (Must Know) (Desirable to know) 1.Introduction to Pathology - Different sections in pathology - The Cell in health - Normal cell structure
More informationHematologic Disorders. Assistant professor of anesthesia
Preoperative Evaluation Hematologic Disorders Dr M.Razavi Assistant professor of anesthesia Anemia Evaluation needs to consider the extent and type of surgery, the anticipated blood loss, and the patient's
More informationFocus on aggressive polycythemia vera
Focus on aggressive polycythemia vera Jerry L. Spivak, MD Professor of Medicine and Oncology Director, the Johns Hopkins Center for the Chronic Myeloproliferative Disorders Johns Hopkins University School
More informationMyelodysplastic Syndromes Myeloproliferative Disorders
Myelodysplastic Syndromes Myeloproliferative Disorders Myelodysplastic Syndromes characterized by maturation defects that are associated with ineffective hematopoiesis and a high risk of transformation
More informationHeme 9 Myeloid neoplasms
Heme 9 Myeloid neoplasms The minimum number of blasts to diagnose acute myeloid leukemia is 5% 10% 20% 50% 80% AML with the best prognosis is AML with recurrent cytogenetic abnormality AML with myelodysplasia
More informationJuly 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244
July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American
More informationQUESTIONS OF HEMATOLOGY AND THEIR ANSWERS
QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS WHAT IS TRUE AND WHAT IS FALSE? Questions 1 Iron deficiency anemia a) Is usually associated with a raised MCV. b) The MCH is usually low. c) Is most commonly due
More informationPolycthemia Vera (Rubra)
Polycthemia Vera (Rubra) Polycthemia Vera (Rubra) Increased red cells Clonal Myeloid lineages also increased 2-13 cases per million Mean age: 60 years Sites of Involvement Bone marrow Peripheral blood
More informationClinical indications for positron emission tomography
Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will
More informationInternal Medicine Certification Examination Blueprint
Internal Medicine Certification Examination Blueprint What Does the Examination Cover? The exam is designed to evaluate the extent of the candidate s knowledge and clinical judgment in the areas in which
More informationWhat is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed? David E. Thaler, MD, PhD, FAHA
What is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed? David E. Thaler, MD, PhD, FAHA Neurologist in Chief, Tufts Medical Center Professor and Chair
More informationPlatelet Disorders. By : Saja Al-Oran
Platelet Disorders By : Saja Al-Oran Introduction The platelet arise from the fragmentation of the cytoplasm of megakaryocyte in the bone marrow. circulate in the blood as disc-shaped anucleate particles
More informationThe primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:
Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist
More informationThe Complete Blood Count
The Complete Blood Count (Cartesian Thinking at Its Best) A SEM Image of Normal Human Blood Laurie Larsson February 22, 2010 Anatomy and Philology II Dr. Danil Hammoudi Introduction A complete blood count
More informationHematologic changes in systemic diseases. Chittima Sirijerachai
Hematologic changes in systemic diseases Chittima Sirijerachai Systemic diseases Infection Renal diseases Liver diseases Connective tissue diseases Malignancy Anemia of chronic disease (ACD) Chronic infections:
More informationDisorders of Blood Cells & Blood Coagulation
Disorders of Blood Cells & Blood Coagulation HIHIM 409 WBC count RBC count WBC differential Hemoglobin (HGB) Hematocrit (HCT) % of volume occupied by RBCs CBC Red cell indices Mean cell volume (MCV) average
More informationDisseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.
Disseminated Intravascular Coagulation (DIC) Seminar Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.2012 1 Our plan: Understand the pathophysiology Identify risk factors
More informationTaking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss
Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside Blood Cell Abnormalities Abnormalities
More informationCerebrovascular Diseases in Cancer Patients
Cerebrovascular Diseases in Cancer Patients Ji-Yong Lee, M.D., Joon-Bum Kwon, M.D., Hyun-Duk Yang, M.D., Seong-Ik Lee, M.D., Bum-Gi Han, M.D., Joon-Shik Moon, M.D., Sung-Soo Lee, M.D. Department of Neurology,
More informationMyeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:
Myeloid neoplasms Note: Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories: 1. AML : Acute myeloid leukemia(stem cell with myeloid
More informationTHE CLASSIFICATION OF ANEMIA*
THE CLASSIFICATION OF ANEMIA* RUSSELL L. HADEN, M.D. SUMMARY A laboratory and clinical classification of anemia has been outlined. The results of the blood study have been correlated with the clinical
More informationHEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint
HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Hematology MOC exam blueprint Based on feedback from physicians that MOC assessments should
More informationHemostatic System - general information
PLATELET DISORDERS Hemostatic System - general information Normal hemostatic system vessel wall circulating blood platelets blood coagulation and fibrynolysis Bleeding Diathesis inherited or acquired defects
More informationDr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College
Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
More informationThrombocytopenia: a practial approach
Thrombocytopenia: a practial approach Dr. med. Jeroen Goede FMH Innere Medizin, Medizinische Onkologie, Hämatologie FAMH Hämatologie Chefarzt Hämatologie Kantonsspital Winterthur Outline Introduction and
More informationReactive thrombocytosis in children
The Turkish Journal of Pediatrics 2013; 55: 411-416 Original Reactive thrombocytosis in children Celal Özcan 1, Tülin Revide Şaylı 2, Vildan Koşan-Çulha 2 2 Division of Pediatric Hematology, 1 Department
More informationSYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.
SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE- Total hours number 70 hours, including course 0 hours, seminars 0 hours. Aim of the subject of Hematology: The study of etiology, pathogenesis,
More informationSymptoms and Signs in Hematology/ 2013
Symptoms and Signs in Hematology/ 2013 Abdallah Abbadi.MD.FRCP Professor of Hematology & Oncology University of Jordan & JUH Email: abdalla.awidi@gmail.com Diseases of Blood & Blood forming organs A- Benign
More informationPeripheral Blood Smear Examination. Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital
1395 Peripheral Blood Smear Examination Momtazmanesh MD. Ped. Hematologist & Oncologist Loghman General Hospital Peripheral Blood Smear A peripheral blood smear is a snapshot of the cells that are present
More information155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary
ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant
More informationAre there still any valid indications for thrombophilia screening in DVT?
Carotid artery stenosis and risk of stroke Are there still any valid indications for thrombophilia screening in DVT? Armando Mansilha MD, PhD, FEBVS Faculty of Medicine of University of Porto Munich, 2016
More informationBlood Cell Identification Graded
Blood Cell Identification Graded Case History The patient was a five-day-old girl with an elevated unconjugated bilirubin and a weakly positive direct antiglobulin test (DAT). Her CBC showed: WBC = 11.0
More informationMyelodysplastic Syndrome: Let s build a definition
1 MDS: Diagnosis and Treatment Update Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian Hospital Myelodysplastic
More informationContents SECTION 1: PHYSIOLOGY OF BLOOD
Contents SECTION 1: PHYSIOLOGY OF BLOOD Chapter 1: Overview of Physiology of Blood 1 Normal Haematopoiesis 1 Red Blood Cells 6 White Blood Cells 15 Immune System 27 Megakaryopoiesis 32 Normal Haemostasis
More informationThe Evaluation and Classification of Anemia
Case studies and research for better care To refer a patient, call. The Evaluation and Classification of Anemia A diagnostic approach BY AMANDA BRANDOW, DO, MS Anemia is defined as hemoglobin concentration
More informationCollect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.
Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,
More informationPremium Specialty: Pediatrics
Premium Specialty: Pediatrics Credentialed Specialties include: Adolescent Medicine, Pediatric Adolescent, and Pediatrics This document is designed to be used in conjunction with the UnitedHealth Premium
More informationMegakaryocyte Abnormalities in Thrombotic Thrombocytopenic Purpura
Megakaryocyte Abnormalities in Thrombotic Thrombocytopenic Purpura LAWRENCE KASS, M.D. Department of Internal Medicine, Simpson Memorial Institute, The University of Michigan, Ann Arbor, Michigan 48105
More informationSTEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL
MAIN OFFICE: (618) 692-7478 MORGUE: (618) 296-4525 FAX: (618) 692-6042 FAX: (618) 692-9304 STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL. 62025-1962
More informationBeyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure
Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for
More informationHCPCS Codes (Alphanumeric, CPT AMA) ICD-9-CM Codes Covered by Medicare Program
HCPCS s (Alphanumeric, CPT AMA) 82272 Blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening ICD-9-CM
More informationApproach to a pale child
Approach to a pale child Dr. Dafalla Ahmed Babiker Jazan university objectives Definition of anemia Classification and causes Important points in history and physical examination Investigations. Definition
More informationVA Hematology/Oncology Elective
VA Hematology/Oncology Elective The Medical Oncology and Hematology section at the Syracuse VA Medical Center is responsible for providing specialized care to our veterans with cancer and blood disorders.
More information2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors
2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors ICD-10 Code Explanation of Code Malignant neoplasms (excluding
More informationAcute Immune Thrombocytopenic Purpura (ITP) in Childhood
Acute Immune Thrombocytopenic Purpura (ITP) in Childhood Guideline developed by Robert Saylors, MD, in collaboration with the ANGELS team. Last reviewed by Robert Saylors, MD September 22, 2016. Key Points
More informationMDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?
101 May 17, 2014 Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine What is bone marrow? What does bone
More informationCancer Epidemiology, Manifestations, and Treatment
Cancer Epidemiology, Manifestations, and Treatment Chapter 10 Environmental Risk Factors Tobacco Ø Multipotent carcinogenic mixture Ø Linked to cancers of the lung, lower urinary tract, digestive tract,
More informationPATHOLOGY & PATHOPHYSIOLOGY
PATHOLOGY & PATHOPHYSIOLOGY DISORDERS OF BLOOD DISORDERS OF BLOOD Disorders of Blood Infections Tumours Nutritional disorders Coagulation disorders Congenital disorders Septicaemia Leukemia Iron deficiency
More informationMost Common Hemostasis Consults: Thrombocytopenia
Most Common Hemostasis Consults: Thrombocytopenia Cindy Neunert, MS MSCS Assistant Professor, Pediatrics CUMC Columbia University TSHNA Meeting, April 15, 2016 Financial Disclosures No relevant financial
More informationLec.2 Medical Physiology Blood Physiology Z.H.Kamil
Destruction of Red Blood Cells When red blood cells are delivered from the bone marrow into the circulatory system, they normally circulate an average of 120 days before being destroyed. Even though mature
More informationPolycythemia Vera and Essential Thombocythemia A Single Institution Experience
INDIAN JOURNAL OF MEDICAL & PAEDIATRIC ONCOLOGY Vol. 29 No 4, 2008 7 Original Article-I Polycythemia Vera and Essential Thombocythemia A Single Institution Experience CECIL ROSS, NAVYA, VANAMALA AND KARUNA
More informationYEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY
1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor
More informationYear 2003 Paper two: Questions supplied by Tricia
QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]
More informationPathology of Hematopoietic and Lymphoid tissue
CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis
More informationGOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD
GOOD MORNING! Thursday, July 10 2014 Heidi Murphy, MD Leslie Carter-King, MD PREP QUESTION Almost all infants experience a transient increase in bilirubin concentrations known as physiologic jaundice during
More informationAssessing thrombocytopenia in the intensive care unit: The past, present, and future
Assessing thrombocytopenia in the intensive care unit: The past, present, and future Ryan Zarychanski MD MSc FRCPC Sections of Critical Care and of Hematology, University of Manitoba Disclosures FINANCIAL
More informationChapter 2 Neoplasms C00-D49 November 11, Chapter 2: Neoplasms Category: C00-D49 Official Coding Guidelines: Section 1.C.2, p.
Chapter 2: Neoplasms Category: C00-D49 Official Coding Guidelines: Section 1.C.2, p. 22 1 C00 C75 Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, hematopoietic
More informationRayos Prior Authorization Program Summary
Rayos Prior Authorization Program Summary FDA APPROVED INDICATIONS AND DOSAGE FDA-Approved Indications: 1 Agent Indication Dosage Rayos (prednisone delayedrelease tablet) as an anti-inflammatory or immunosuppressive
More informationAbstracting Hematopoietic Neoplasms
CASE 1: LYMPHOMA PHYSICAL EXAMINATION 43yo male with a history of lower gastrointestinal bleeding and melena undergoing colonoscopy and biopsy to rule out neoplasm versus inflammation. Patient had no other
More informationChronic Myeloproliferative Disorders
1 Chronic Myeloproliferative Disorders 15th 9 April2015 Polycythemia vera Essential thrombocythemia Idiopathic primary myelofibrosis 2 Learning objectives To appreciate types of polycythaemia (erythrocytosis)
More informationرناد زكريا Dr. ahmad Dr. ahmad. P a g e 1
5 رناد زكريا Dr. ahmad Dr. ahmad P a g e 1 Before we start. -This sheet was written according to section 2 s record and reviewed according to section 1 s record by Ruba Hussien with all thanks and I referred
More informationDeconstructing the CBC
Deconstructing the CBC Dr. Ann M. Wexler Solano Hematology Oncology September 10, 2017 What Are the Major Components of Blood? Red Blood Cells (also called erythrocytes) White Blood Cells (also called
More informationInstructor s Manual Chapter 26 Hematological Alterations. 1. A man and woman both test positive for the sickle cell trait. The couple asks the
1 Instructor s Manual Chapter 26 Hematological Alterations Answers to Study Questions 1. A man and woman both test positive for the sickle cell trait. The couple asks the nurse how many of their children
More informationAnemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi
Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH
More informationMDS: Who gets it and how is it diagnosed?
MDS: Who gets it and how is it diagnosed? October 16, 2010 Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian
More informationLAB TIME/DATE. 1. most numerous leukocyte. 3. also called an erythrocyte; anucleate formed element. 6. ancestral cell of platelets
ighapmlre29apg245_250 5/12/04 2:46 PM Page 245 impos03 302:bjighapmL:ighapmLrevshts:layouts: NAME Blood LAB TIME/DATE REVIEW SHEET exercise 29A Composition of Blood 1. What is the blood volume of an average-size
More informationIron-deficiency anemia as a rare cause of cerebral venous thrombosis and pulmonary embolism. NICASTRO, Nicolas, SCHNIDER, Armin, LEEMANN, Béatrice
Article Iron-deficiency anemia as a rare cause of cerebral venous thrombosis and pulmonary embolism NICASTRO, Nicolas, SCHNIDER, Armin, LEEMANN, Béatrice Abstract Cerebral venous thrombosis (CVT) is a
More informationTechnical Bulletin No. 100
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 100 August 2, 2012 JAK2 AND MPL 515 MUTATIONAL ANALYSIS Contact: Dr. Jeffrey Wisotzkey, 717-851-1422 Technical Director, CPAL Jill A.
More informationCLINICAL POLICY DEPARTMENT: Medical Management DOCUMENT NAME: JakafiTM REFERENCE NUMBER: NH.PHAR.98
PAGE: 1 of 6 IMPORTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of generally accepted
More informationCase Report Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report
Hindawi Case Reports in Hematology Volume 2017, Article ID 3725089, 4 pages https://doi.org/10.1155/2017/3725089 Case Report Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature
More informationDETERMINATION OF THE LIFE SPAN OF HUMAN BLOOD PLATELETS USING LABELLED DIISOPROPYLFLUOROPHOSPHONATE
DETERMINATION OF THE LIFE SPAN OF HUMAN BLOOD PLATELETS USING LABELLED DIISOPROPYLFLUOROPHOSPHONATE C. H. W. Leeksma, J. A. Cohen J Clin Invest. 1956;35(9):964-969. https://doi.org/10.1172/jci103356. Research
More informationCalifornia Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar
Production Automation and Quality Control Unit Data Alert - Registrar 2015-063 REVISED - Clarification Casefinding List for FY2016 Updated Please see additional codes inadvertently excluded from the previous
More informationNew Surgical Oncology Clinic at Nationwide Children s Hospital
Hematology/Oncology & BMT New Surgical Oncology Clinic at Nationwide Children s Hospital This clinic offers convenient, comprehensive care for patients with cancer. Here, in one visit, pediatric patients
More informationBONE MARROW PERIPHERAL BLOOD Erythrocyte
None Disclaimer Objectives Define anemia Classify anemia according to pathogenesis & clinical significance Understand Red cell indices Relate the red cell indices with type of anemia Interpret CBC to approach
More informationCalifornia Association for Medical Laboratory Technology
California Association for Medical Laboratory Technology HEMATOLOGY CASE STUDIES: PLATELETS Distance Learning Program Course # DL-985 Helen M. Sowers, MA, CLS, Dept of Biological Science (retired) CSU,
More informationPATIENT INFORMATION FROM YOUR SURGEON & SAGES. Laparoscopic Spleen Removal (Splenectomy)
Patient Information published on: 03/2004 by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) PATIENT INFORMATION FROM YOUR SURGEON & SAGES Laparoscopic Spleen Removal (Splenectomy)
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited
More information2013 Pathology Student
About this guide If you re reading this introduction, it means you are probably either a) covering hematopathology in your pathology class right now, or b) studying for boards. Either way, you ve come
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423
More informationCalifornia Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar
Production Automation and Quality Control Unit Data Alert - Registrar 2015-061 REVISED Casefinding List FY2016 Please see additions and revisions noted below in red text. ICD-10-CM Codes have been adopted
More informationMicrocytic Hypochromic Anemia An Approach to Diagnosis
Microcytic Hypochromic Anemia An Approach to Diagnosis Decreased hemoglobin synthesis gives rise to microcytic hypochromic anemias. Hypochromic anemias are characterized by normal cellular proliferation
More information